BARCELONA, Spain — New data from EXAMINE, the cardiovascular-safety trial with the type 2 diabetes drug alogliptin (Nesina, Takeda Pharmaceuticals), has shown no significantly increased risk for heart ...

Dipeptidyl peptidase 4 (DPP-4) inhibitors (commonly referred to as gliptins) are a novel class of oral antihyperglycaemic agents with demonstrated efficacy in the treatment of type 2 diabetes mellitus ...

NOTTINGHAM, UK — In a population-based cohort of patients with type 2 diabetes who were seen in the past decade in clinical practices in the UK, those who received thiazolidinediones (TZDs or ...

Gliptins should be used more widely in patients with diabetes as they are associated with less weight gain and fewer hypoglycaemic episodes than sulfonylureas, say researchers. In findings that could ...

The researchers say the technology could eventually support more personalised care, allowing treatments to be better matched ...

MUMBAI: A new anti-diabetes drug from the ‘gliptin’ family soon to be launched in India promises to lower treatment cost for patients by 55-60%. The launch of ‘Teneligliptin’ by Mumbai-based Glenmark ...

With all the controversy surrounding the long-term side effects of anti-diabetic drugs, diabetologists have decided to put in extra effort to ensure that benefits overweigh the risks when they ...

(HealthDay News) — Gliptin treatment is associated with increased acute pancreatitis risk, according to research published online Sept. 22 in Diabetes Care. Ivan Tkac, M.D., Ph.D., from Pasteur ...

Diabetes is considered a risk factor for Alzheimer's disease. Several studies have shown that people with prediabetes or type 2 diabetes have a higher risk of getting Alzheimer's disease and other ...

MUMBAI: In a move that could potentially disrupt the anti-diabetes drug market in India and lead to a price war, Ahmedabad based Zydus Cadila on Friday said it launched its brand Tenglyn, pricing it ...

As we age, it becomes harder to heal from injuries, in part because stem cells throughout the body lose their regenerative oomph. Scientists at Scripps Research reported this week on a molecule that ...